InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Pluri Inc.

PLUR Clue Score47
United States Fiscal year ends June CIK 0001158780
$0.95 -4.68% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.95 −61.87% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Operating income−28.0Net income−27.8Fiscal year 2018Revenue0.1Operating income−33.7Net income−26.1Fiscal year 2019Revenue0.1 +8.0%Operating income−35.5Net income−35.3Fiscal year 2020Revenue0.0 −57.4%Operating income−29.5Net income−29.2Fiscal year 2021Operating income−50.6Net income−49.9EPS, diluted−1.77Fiscal year 2022Revenue0.2Operating income−41.6Net income−41.2EPS, diluted−1.28Fiscal year 2023Revenue0.3 +22.6%Operating income−27.2Net income−28.3EPS, diluted−6.24Fiscal year 2024Revenue0.3 +13.6%Operating income−22.2Net income−20.9EPS, diluted−3.99Fiscal year 2025Revenue1.3 +309.8%Operating income−22.2Net income−22.6EPS, diluted−3.56Fiscal year 2026Revenue1.0 −24.0%Operating income−24.9Net income−23.8EPS, diluted−2.44
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue n/a 0.1 0.1 0.0 n/a 0.2 0.3 0.3 1.3 1.0
Growth +8.0% −57.4% +22.6% +13.6% +309.8% −24.0%
Operating income −28.0 −33.7 −35.5 −29.5 −50.6 −41.6 −27.2 −22.2 −22.2 −24.9
Net income −27.8 −26.1 −35.3 −29.2 −49.9 −41.2 −28.3 −20.9 −22.6 −23.8
Growth
EPS, diluted n/a n/a n/a n/a −1.77 −1.28 −6.24 −3.99 −3.56 −2.44

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Fiscal year 2018Gross margin96.0%Operating margin−67,462.0%Net margin−52,252.0%Free cash flow margin−43,444.0%Fiscal year 2019Gross margin96.3%Operating margin−65,800.0%Net margin−65,383.3%Free cash flow margin−54,985.2%Fiscal year 2020Gross margin100.0%Operating margin−128,156.5%Net margin−126,747.8%Free cash flow margin−115,821.7%Fiscal year 2021Fiscal year 2022Gross margin100.0%Operating margin−17,774.8%Net margin−17,624.8%Free cash flow margin−15,718.4%Fiscal year 2023Gross margin96.9%Operating margin−9,493.4%Net margin−9,867.9%Free cash flow margin−8,055.4%Fiscal year 2024Gross margin98.8%Operating margin−6,796.9%Net margin−6,407.4%Free cash flow margin−5,627.0%Fiscal year 2025Gross margin49.0%Operating margin−1,659.9%Net margin−1,690.3%Free cash flow margin−1,484.2%Fiscal year 2026Gross margin44.6%Operating margin−2,454.5%Net margin−2,344.6%Free cash flow margin−1,990.3%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Gross margin n/a 96.0% 96.3% 100.0% n/a 100.0% 96.9% 98.8% 49.0% 44.6%
Operating margin n/a −67,462.0% −65,800.0% −128,156.5% n/a −17,774.8% −9,493.4% −6,796.9% −1,659.9% −2,454.5%
Net margin n/a −52,252.0% −65,383.3% −126,747.8% n/a −17,624.8% −9,867.9% −6,407.4% −1,690.3% −2,344.6%
Free cash flow margin n/a −43,444.0% −54,985.2% −115,821.7% n/a −15,718.4% −8,055.4% −5,627.0% −1,484.2% −1,990.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−21.6Capital expenditure−0.4Free cash flow−22.0Fiscal year 2018Operating cash flow−21.4Capital expenditure−0.3Free cash flow−21.7Fiscal year 2019Operating cash flow−29.5Capital expenditure−0.2Free cash flow−29.7Fiscal year 2020Operating cash flow−26.4Capital expenditure−0.3Free cash flow−26.6Fiscal year 2021Operating cash flow−30.9Capital expenditure−0.4Free cash flow−31.3Fiscal year 2022Operating cash flow−36.5Capital expenditure−0.3Free cash flow−36.8Fiscal year 2023Operating cash flow−22.9Capital expenditure−0.3Free cash flow−23.1Fiscal year 2024Operating cash flow−18.0Capital expenditure−0.3Free cash flow−18.3Fiscal year 2025Operating cash flow−18.2Capital expenditure−1.6Free cash flow−19.8Fiscal year 2026Operating cash flow−19.6Capital expenditure−0.6Free cash flow−20.2
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −21.6 −21.4 −29.5 −26.4 −30.9 −36.5 −22.9 −18.0 −18.2 −19.6
Capital expenditure −0.4 −0.3 −0.2 −0.3 −0.4 −0.3 −0.3 −0.3 −1.6 −0.6
Free cash flow −22.0 −21.7 −29.7 −26.6 −31.3 −36.8 −23.1 −18.3 −19.8 −20.2
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash4.7Shareholders’ equity30.3Fiscal year 2018Cash8.8Shareholders’ equity28.5Fiscal year 2019Cash4.1Shareholders’ equity21.8Fiscal year 2020Cash8.3Shareholders’ equity56.1Fiscal year 2021Cash31.2Shareholders’ equity57.2Fiscal year 2022Cash9.8Shareholders’ equity30.0Fiscal year 2023Cash5.4Shareholders’ equity13.4Fiscal year 2024Cash6.8Shareholders’ equity0.1Fiscal year 2025Cash5.9Shareholders’ equity−6.8Fiscal year 2026Cash3.5Shareholders’ equity−23.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 4.7 8.8 4.1 8.3 31.2 9.8 5.4 6.8 5.9 3.5
Shareholders’ equity 30.3 28.5 21.8 56.1 57.2 30.0 13.4 0.1 −6.8 −23.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021 30 Jun 2021 FY2022 30 Jun 2022 FY2023† 30 Jun 2023 FY2024 30 Jun 2024 FY2025 30 Jun 2025 FY2026† 30 Jun 2026
Revenue and profit
n/a 0.1 0.1 0.0 n/a 0.2 0.3 0.3 1.3 1.0
Growth +8.0% −57.4% +22.6% +13.6% +309.8% −24.0%
n/a 0.0 0.0 n/a n/a n/a 0.0 0.0 0.7 0.6
n/a 0.0 0.1 0.0 n/a 0.2 0.3 0.3 0.7 0.5
Growth +8.3% −55.8% +18.8% +15.8% +103.1% −30.7%
24.0 26.4 29.9 23.1 30.5 24.6 15.7 12.4 12.9 15.1
6.9 11.2 9.2 7.9 20.6 17.5 11.8 10.0 10.0 10.3
−28.0 −33.7 −35.5 −29.5 −50.6 −41.6 −27.2 −22.2 −22.2 −24.9
Growth
n/a n/a n/a n/a n/a n/a n/a −21.3 −23.3 −25.4
n/a n/a n/a n/a n/a n/a n/a n/a −0.0 −0.0
−27.8 −26.1 −35.3 −29.2 −49.9 −41.2 −28.3 −20.9 −22.6 −23.8
Growth
Per share
n/a n/a n/a n/a −1.77 −1.28 −6.24 −3.99 −3.56 −2.44
n/a n/a n/a n/a −1.77 −1.28 −6.24 −3.99 −3.56 −2.44
Growth
n/a n/a n/a n/a 28.1 32.2 4.6 5.2 6.3 9.7
n/a n/a n/a n/a n/a 32.2 4.6 5.2 6.3 9.7
Growth −85.8% +14.4% +20.9% +53.8%

† The diluted share count jumps at 2023 and 2026, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 113.3% a year over five years.
  • Operating margin is up 125,702.0 points on five years ago, at -2,454.5%.
  • A net loss in 10 of 10 years on file.